BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics
- 24 August 2016
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 56 (2) , 313-316
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologicsRheumatology, 2013
- BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapiesRheumatology, 2010
- Frequency and characteristics of disease flares in ankylosing spondylitisRheumatology, 2010
- The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohortArthritis & Rheumatism, 2009
- BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for RheumatologyRheumatology, 2005
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984